~~<i id='CA1F5B6959'><strike id='CA1F5B6959'><tt id='CA1F5B6959'><pre id='CA1F5B6959'></pre></tt></strike></i>~~

Home» leisure time» entertainment

entertainment

author：comprehensive 2025-09-29 07:22:13 Page View：768

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What Henrietta Lacks settlement says about racism in medicine
Next article： In age of alternative facts, a scholarly course on calling out crap

explore

In Memoriam: Notable people who died in 2023

1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

A cyberattack has disrupted hospitals and health care in several states

TheSouthernCaliforniaHospitalatHollywoodisseenintheHollywooddistrictofLosAngelesonFriday,Aug.4,2023.

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Can U.S. cancer drug shortages be fixed?

AdobeRoughlytwomillionAmericansareexpectedtoreceiveacancerdiagnosisthisyear.Somemembersofthisalready